FINANCE
Investors take action on market opportunities
"It allows us to stay on top of clinical trials while understanding what is driving various shifts so we can prepare our next moves."
Analyst, Biopharma
$25B AUM Hedge Fund
$25B AUM Hedge Fund
Public Markets
Anticipate negative outcomes for specific trials so you can recognize shorting and divesting opportunities before anyone else.
Venture Capital
Discover under the radar biotech companies across emerging therapeutic areas so you can find your next big bet.